Portfolio company Neuronostics raise over £2M in oversubscribed seed round

by Harry | Apr 5, 2024 | Portfolio

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

by Harry | Mar 27, 2024 | Portfolio

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

by Harry Alexander | Feb 16, 2023 | Healthcare, Portfolio

Headline: Rapid diagnostic technology spun out from the University of Southampton can identify antibiotic resistance 10x faster than current gold standards Working closely with UKHSA at the world-leading microbiology labs in Porton Down to demonstrate clinical...

QantX invests in Watercress Research

by Harry Alexander | Oct 24, 2022 | Healthcare, Portfolio

We’re happy to announce that QantX have completed an investment into Watercress Research, a pioneering startup developing processes to extract clinically useful products from the peppery salad leaf, watercress (Nasturtium Officinale). Watercress, a member of the...